Mouth ulcer treatment and flurbiprofen to be downscheduled, TGA announces The Therapeutic Goods Administration has confirmed that the mouth ulcer treatment choline salicylate is to be downscheduled to Schedule 2 (Pharmacy Only). There will also be changes to the S2 listing for Flurbirpofen, allowing general sale of some preparations, the TGA confirmed. These were among
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.